3 Reasons Why Growth Investors Shouldn't Overlook Itron (ITRI)

Itron (ITRI) has been identified by Zacks Investment Research as a promising growth stock, earning a Zacks Growth Score of B and a Zacks Rank #2 (Buy). This positive outlook is underpinned by strong financial indicators, including a projected 6.5% EPS growth for the current year, which outpaces the industry average of 5.6%. Additionally, Itron exhibits robust year-over-year cash flow growth of 50.8%, significantly above the industry's 11.3%, and has seen current-year earnings estimates revised upward by 11.3% over the past month, signaling potential outperformance for growth-oriented investors.

Analysis

Itron (ITRI) has been identified as a compelling growth stock, supported by a Zacks Rank #2 (Buy) and a Growth Score of B. The bullish thesis is anchored by several strong quantitative indicators. The company's projected EPS growth for the current year stands at 6.5%, favorably outpacing the industry average of 5.6%. More significantly, Itron demonstrates robust liquidity and operational efficiency with a year-over-year cash flow growth of 50.8%, which is substantially higher than the 11.3% industry average. This suggests a strong capacity for self-funded expansion. Reinforcing this positive outlook, the Zacks Consensus Estimate for current-year earnings has been revised upward by 11.3% over the past month, a metric strongly correlated with near-term stock price movements according to the underlying research methodology. While its historical 3-5 year annualized cash flow growth of 4.9% is only slightly above the industry's 4.4%, the recent acceleration in cash generation and positive earnings revisions are the primary drivers of its current favorable rating.

Key Decisions for Investors

• Given the combination of a Zacks #2 (Buy) rank, strong growth metrics, and positive earnings revisions, growth-focused investors should consider Itron a candidate for a long position.
• It is critical to monitor the trend in earnings estimate revisions, as the recent 11.3% upward revision is highlighted as a key potential driver for near-term price appreciation.
• Investors should track whether Itron can sustain its significant outperformance in year-over-year cash flow growth and meet its projected EPS growth, as these factors are central to the current investment thesis.